Skip to main content
. 2020 Mar 17;13:2311–2317. doi: 10.2147/OTT.S235882

Figure 3.

Figure 3

Morphological CR status and number of lymphoblasts in the bone marrow at different times. Autologous anti-CD19 CAR T cells bridging with allo-HSCT post CR3. CR4 was obtained followed by sequential of infusion donor-derived anti-CD22 and -CD19 CAR T cells.